Obtaining the building permit for the construction of Svilno 2 officially marks the beginning of the new and most important investment project of JGL worth EUR 45 million. The 78 000 m2 construction plot has so far been used for the production of concrete and concrete blocks; now it will serve for the expansion of our production capacity.
This will allow the integration of all JGL’s business operations that have so far been carried out on several locations in Rijeka into a single location, and will help us achieve our plans for growth.
The Svilno 2 complex, also known as “pharma valley”, will present an extension of the existing production location in Svilno 1 and will bring to the company significant development, production and storage capacities that will also help ensure key resources for the achievement of planned and profitable horizontal growth over the period of five years and longer.
Considering that the company focuses on the development and production of drugs for the senses, additional capacities and the technical equipment of new plants for sterile solutions will certainly help JGL’s key brands to take a further step forward onto the global health market.
The project is extremely complex, it includes major reconstruction, conversion and upgrade to the existing facilities and will be realized in phases, according to the established plan. The biggest part of phase 1 works will begin mid-2013 and the completion is planned for May 2014.
The new production and technological investment will certainly change the skyline of Rijeka and serve as an impetus for employment and economic development.